ResearcherSecond Military Medical UniversityActive in the last 2 years

Weidong Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-1093-5817; OpenAlex author ID A5107950213. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Expanding the ubiquitin code in pancreatic cancer. Co-author DOI 10.1016/j.bbadis.2023.166884 ↗
Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review. Last author DOI 10.1186/s12964-019-0435-2 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiang‐Jiang Qin · 2 shared papers, 2019–2024 · strength 0.42
- Paper Expanding the ubiquitin code in pancreatic cancer. DOI 10.1016/j.bbadis.2023.166884 ↗
- Paper Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review. DOI 10.1186/s12964-019-0435-2 ↗
Shiqun Wang · 1 shared paper, 2024 · strength 0.28
- Paper Expanding the ubiquitin code in pancreatic cancer. DOI 10.1016/j.bbadis.2023.166884 ↗
Wenyan Yang · 1 shared paper, 2024 · strength 0.28
- Paper Expanding the ubiquitin code in pancreatic cancer. DOI 10.1016/j.bbadis.2023.166884 ↗
Xiangdong Cheng · 1 shared paper, 2019 · strength 0.14
- Paper Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review. DOI 10.1186/s12964-019-0435-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.